Historical data shows that a consistent $500 monthly investment into Dyne Therapeutics, Inc. (DYN) starting in 2020 would have turned a total investment of $45K into $58K today. This represents a total return of 29.7% over the 6-year period, compounding through dividend reinvestment and market growth.
The Impact of Dividend Reinvestment (DRIP)
Dyne Therapeutics, Inc. does not currently pay a notable dividend. For growth-focused stocks like DYN, dollar cost averaging relies entirely on price appreciation. Over the 6-year period, the strategy successfully captured the stock's price movements, resulting in a final portfolio value of $58K without the need for dividend reinvestment.
DYN vs. S&P 500 (SPY) Benchmark
When comparing this dollar cost averaging strategy against a broad market index,DYN underperformed the S&P 500 ETF (SPY). The same $500 monthly contributions into SPY would have grown to $76K, compared to DYN's $58K.